SHLT vs. LFMD, AIRS, PTWO, TOI, CANOQ, CCM, HIMS, TDOC, AUNA, and ACB
Should you be buying SHL Telemedicine stock or one of its competitors? The main competitors of SHL Telemedicine include LifeMD (LFMD), AirSculpt Technologies (AIRS), Pono Capital Two (PTWO), Oncology Institute (TOI), Cano Health (CANOQ), Concord Medical Services (CCM), Hims & Hers Health (HIMS), Teladoc Health (TDOC), Auna (AUNA), and Aurora Cannabis (ACB).
SHL Telemedicine (NASDAQ:SHLT) and LifeMD (NASDAQ:LFMD) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their community ranking, valuation, media sentiment, dividends, analyst recommendations, risk, earnings, profitability and institutional ownership.
In the previous week, LifeMD had 5 more articles in the media than SHL Telemedicine. MarketBeat recorded 5 mentions for LifeMD and 0 mentions for SHL Telemedicine. LifeMD's average media sentiment score of 0.85 beat SHL Telemedicine's score of 0.00 indicating that LifeMD is being referred to more favorably in the news media.
LifeMD received 27 more outperform votes than SHL Telemedicine when rated by MarketBeat users. However, 100.00% of users gave SHL Telemedicine an outperform vote while only 71.79% of users gave LifeMD an outperform vote.
SHL Telemedicine presently has a consensus price target of $11.00, suggesting a potential upside of 100.00%. LifeMD has a consensus price target of $12.50, suggesting a potential upside of 65.78%. Given SHL Telemedicine's higher probable upside, analysts clearly believe SHL Telemedicine is more favorable than LifeMD.
20.1% of SHL Telemedicine shares are held by institutional investors. Comparatively, 35.5% of LifeMD shares are held by institutional investors. 18.9% of LifeMD shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
SHL Telemedicine has a beta of -0.59, suggesting that its stock price is 159% less volatile than the S&P 500. Comparatively, LifeMD has a beta of 1.16, suggesting that its stock price is 16% more volatile than the S&P 500.
SHL Telemedicine has a net margin of 0.00% compared to LifeMD's net margin of -14.75%.
SHL Telemedicine has higher earnings, but lower revenue than LifeMD.
Summary
LifeMD beats SHL Telemedicine on 9 of the 14 factors compared between the two stocks.
Get SHL Telemedicine News Delivered to You Automatically
Sign up to receive the latest news and ratings for SHLT and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SHLT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
SHL Telemedicine Competitors List
Related Companies and Tools
